ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,406Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 305

$1.69M Total Retail Price of All Prescriptions

Rank: 28 out of 305

483 Patients Receiving at Least One Drug in Part D
9% Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Michigan
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$136 was the average price of a prescription from this provider, compared to $343 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Michigan
QUETIAPINE FUMARATE 700 64 80 A 1 29
BENZTROPINE MESYLATE 649 42 91 R 2 67
CLONAZEPAM 590 38 83 B 3 9
TRAZODONE HCL 585 45 91 4 40
CLOZAPINE 520 40 37 A 5 82
DIVALPROEX SODIUM ER 489 36 63 6 20
SERTRALINE HCL 459 57 64 7 24
RISPERIDONE 424 37 67 A 8 54
CITALOPRAM HBR 418 19 63 9 23
LAMOTRIGINE 405 28 54 10 8
ZIPRASIDONE HCL 398 31 48 A 11 95
ABILIFY 387 63 45 A 12 79
HALOPERIDOL 380 49 49 A 13 96
OLANZAPINE 346 30 46 A 14 98
LORAZEPAM 307 29 54 B 15 41
DIVALPROEX SODIUM 299 34 38 16 17
FLUOXETINE HCL 280 57 41 17 53
OXCARBAZEPINE 238 <11 34 18 22
FLUPHENAZINE HCL 225 14 41 A 19 120
RISPERDAL CONSTA 213 <11 17 A 20 124
ALPRAZOLAM 213 24 33 B 20 18
HALOPERIDOL DECANOATE 212 18 33 A 22 126
ESCITALOPRAM OXALATE 200 22 23 23 39
INVEGA SUSTENNA 191 0 26 A 24 135
MIRTAZAPINE 188 <11 33 25 78
LITHIUM CARBONATE 186 14 24 26 104
GABAPENTIN 170 <11 25 27 1
CYMBALTA 168 19 27 28 30
BUPROPION XL 146 0 15 29 92
SEROQUEL XR 145 13 19 A 30 148
TOPIRAMATE 142 12 14 31 6
BUSPIRONE HCL 126 <11 21 32 103
BUPROPION HCL SR 124 11 18 33 108
DOXEPIN HCL 113 <11 15 34 86
VENLAFAXINE HCL ER 99 <11 12 35 62
TRIHEXYPHENIDYL HCL 95 0 13 R 36 114
CLOZAPINE ODT 91 0 12 A 37 164
INVEGA 85 0 11 A 38 167
FAZACLO 85 <11 <11 A 38 167
PAROXETINE HCL 76 15 11 40 76
OLANZAPINE ODT 67 <11 <11 A 41 184
CARBAMAZEPINE 62 <11 12 42 14
VENLAFAXINE HCL 61 <11 <11 43 190
TRIFLUOPERAZINE HCL 57 <11 <11 A 44 198
DONEPEZIL HCL 53 <11 <11 45 4
LATUDA 51 <11 <11 A 46 214
VALPROIC ACID* 50 <11 <11 47 159
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.